Meniere’s Disease Treatment Market Highlights

The Meniere’s Disease Treatment Market is expected to reach USD 1351.67 Million by 2030 at 3.10% CAGR during the forecast period 2022-2030.

Meniere’s disease is a disorder of the inner ear that can lead to vertigo, tinnitus, and progressive deafness. The disease can develop at any age, but most commonly appears between the age of 40 to 60 years and normally affects only one ear. There is no cure for Meniere’s disease, but certain treatments can help reduce the severity and frequency of vertigo episodes.

Factors such as the high prevalence rate of Meniere’s disease and government initiatives to create awareness regarding vestibular disorders in developed countries are driving the market growth. However, factors such as lack of awareness in developing countries, and adverse side effects of symptomatic treatments are hampering the growth of the Meniere’s disease treatment market. A strong pipeline focusing on developing a specific treatment for Meniere’s disease serves as an opportunity for the growth of the Meniere’s disease treatment market.

Segment Analysis

The Global Meniere’s Disease Treatment Market is segmented into treatment and end-user. Based on treatment, the market has been segmented into the drug, injections, positive pressure therapy, and surgery. The drug segment has been further sub-segmented into anti vertigo drugs, diuretics and others. The injectables are further sub-segmented into steroid injections and gentamicin injections. The surgery segment is further sub-segmented into endolymphatic sac surgery, vestibular nerve section, labyrinthectomy and other. On the basis of end-user, the market has been segmented into hospitals and clinics, specialty centers, and others.

Regional Analysis

The Global Meniere’s Disease Treatment Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas accounted for the largest share in global Meniere’s disease treatment market. This is owing to the increasing prevalence of Meniere’s Disease in the US and the rising number of market players focusing on Meniere’s disease-specific treatment. Moreover, manufacturers such as Otonomy and Sound Pharmaceuticals, with a presence in the US, are focusing on developing drugs specific to Meniere’s disease.

The European market holds the second-largest position in the global Meniere’s disease treatment market due to the rising prevalence of hearing disorders and growing initiatives to create awareness regarding vestibular disorders are driving the market growth

Asia-Pacific is estimated to be the fastest-growing region in Meniere’s disease treatment market. The increasing prevalence of vestibular disorders in the region is blooming the growth of Meniere’s disease treatment market. A majority of companies in Asia-Pacific are committed to investing in research and development of advanced treatments, which will ultimately boost the growth of the market.  

The market in the Middle East & Africa is likely to exhibit the lowest growth owing to the limited access and availability of treatment facilities. Moreover, limited developments in technology may slow the market growth rate in this region.

Key Players

MRFR recognizes the following companies as the Key Global Meniere’s Disease Treatment Market players— Sound Pharmaceuticals (US), LiNA Medical ApS (Europe), Wallace Pharma (India), Jubilant Cadista(US), Pfizer Inc. (US), Glenmark Pharmaceuticals (India), GlaxoSmithKline PLC (UK), WellSpring Pharmaceutical Corporation (US), Auris Medical (Bermuda), Otonomy, Inc. (US) and others.

Key Findings of the Study

·       The Meniere’s Disease Treatment Market is expected to reach USD 1351.67 Million by 2030 at 3.10% CAGR during the forecast period 2022-2030.

·       America accounted for the largest share of the global market due to the presence of a large number of pharmaceutical companies such as Jubilant Cadista, Pfizer Inc., WellSpring Pharmaceutical Corporation, and others offering Meniere’s treatment drugs.

·       Based on treatment, the drug segment accounted for the largest market share.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com